262 related articles for article (PubMed ID: 21415158)
21. Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patients.
Winkler K; Wanner C; Drechsler C; Lilienthal J; März W; Krane V;
Eur Heart J; 2008 Sep; 29(17):2092-9. PubMed ID: 18617483
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Value of Copeptin in Chronic Kidney Disease: From General Population to End-Stage Renal Disease.
Golembiewska E; Machowska A; Stenvinkel P; Lindholm B
Curr Protein Pept Sci; 2017; 18(12):1232-1243. PubMed ID: 28714397
[TBL] [Abstract][Full Text] [Related]
23. Quantification of HDL proteins, cardiac events, and mortality in patients with type 2 diabetes on hemodialysis.
Kopecky C; Genser B; Drechsler C; Krane V; Kaltenecker CC; Hengstschläger M; März W; Wanner C; Säemann MD; Weichhart T
Clin J Am Soc Nephrol; 2015 Feb; 10(2):224-31. PubMed ID: 25424990
[TBL] [Abstract][Full Text] [Related]
24. Is the association of serum sodium with mortality in patients with type 2 diabetes explained by copeptin or NT-proBNP? (ZODIAC-46).
Riphagen IJ; Logtenberg SJ; Groenier KH; van Hateren KJ; Landman GW; Struck J; Navis G; Kootstra-Ros JE; Kema IP; Bilo HJ; Kleefstra N; Bakker SJ
Atherosclerosis; 2015 Sep; 242(1):179-85. PubMed ID: 26201002
[TBL] [Abstract][Full Text] [Related]
25. Plasma Copeptin, Kidney Outcomes, Ischemic Heart Disease, and All-Cause Mortality in People With Long-standing Type 1 Diabetes.
Velho G; El Boustany R; Lefèvre G; Mohammedi K; Fumeron F; Potier L; Bankir L; Bouby N; Hadjadj S; Marre M; Roussel R
Diabetes Care; 2016 Dec; 39(12):2288-2295. PubMed ID: 27729425
[TBL] [Abstract][Full Text] [Related]
26. Copeptin, a surrogate marker for arginine vasopressin, is associated with declining glomerular filtration in patients with diabetes mellitus (ZODIAC-33).
Boertien WE; Riphagen IJ; Drion I; Alkhalaf A; Bakker SJ; Groenier KH; Struck J; de Jong PE; Bilo HJ; Kleefstra N; Gansevoort RT
Diabetologia; 2013 Aug; 56(8):1680-8. PubMed ID: 23624546
[TBL] [Abstract][Full Text] [Related]
27. C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study.
Khan SQ; Dhillon OS; O'Brien RJ; Struck J; Quinn PA; Morgenthaler NG; Squire IB; Davies JE; Bergmann A; Ng LL
Circulation; 2007 Apr; 115(16):2103-10. PubMed ID: 17420344
[TBL] [Abstract][Full Text] [Related]
28. Copeptin - a new diagnostic and prognostic biomarker in neurological and cardiovascular diseases.
Baranowska B; Kochanowski J
Neuro Endocrinol Lett; 2019 Dec; 40(5):207-214. PubMed ID: 32112544
[TBL] [Abstract][Full Text] [Related]
29. Copeptin is an independent prognostic factor for transplant-free survival in cirrhosis.
Kerbert AJ; Weil D; Verspaget HW; Moréno JP; van Hoek B; Cervoni JP; Di Martino V; Coenraad MJ; Thevenot T
Liver Int; 2016 Apr; 36(4):530-7. PubMed ID: 26502363
[TBL] [Abstract][Full Text] [Related]
30. Copeptin is an independent predictor of diabetic heart disease and death.
Enhörning S; Hedblad B; Nilsson PM; Engström G; Melander O
Am Heart J; 2015 Apr; 169(4):549-56.e1. PubMed ID: 25819862
[TBL] [Abstract][Full Text] [Related]
31. Association of hyponatremia and elevated copeptin with death and need for transplantation in ambulatory patients with chronic heart failure.
Miller WL; Grill DE; Struck J; Jaffe AS
Am J Cardiol; 2013 Mar; 111(6):880-5. PubMed ID: 23276468
[TBL] [Abstract][Full Text] [Related]
32. Thyroid function, cardiovascular events, and mortality in diabetic hemodialysis patients.
Drechsler C; Schneider A; Gutjahr-Lengsfeld L; Kroiss M; Carrero JJ; Krane V; Allolio B; Wanner C; Fassnacht M
Am J Kidney Dis; 2014 Jun; 63(6):988-96. PubMed ID: 24315768
[TBL] [Abstract][Full Text] [Related]
33. Potential Clinical Utility of Copeptin (C-terminal provasopressin) measurements in clinical medicine.
Lewandowski KC; Brabant G
Exp Clin Endocrinol Diabetes; 2016 Mar; 124(3):173-7. PubMed ID: 27008633
[TBL] [Abstract][Full Text] [Related]
34. Postsurgical utility of copeptin for the prediction of postoperative arginine vasopressin deficiency.
Donegan D; Bornhorst J; Van Gompel J; Atkinson J; Theobald JP; Meyer FF; Link MJ; Peris-Celda M; Spears G; Erickson D
J Neurosurg; 2024 May; 140(5):1276-1284. PubMed ID: 37948691
[TBL] [Abstract][Full Text] [Related]
35. Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.
Callahan A; Amarenco P; Goldstein LB; Sillesen H; Messig M; Samsa GP; Altafullah I; Ledbetter LY; MacLeod MJ; Scott R; Hennerici M; Zivin JA; Welch KM;
Arch Neurol; 2011 Oct; 68(10):1245-51. PubMed ID: 21670382
[TBL] [Abstract][Full Text] [Related]
36. Copeptin and renal function decline, cardiovascular events and mortality in type 1 diabetes.
Heinrich NS; Theilade S; Winther SA; Tofte N; Ahluwalia TS; Jeppesen JL; Persson F; Hansen TW; Goetze JP; Rossing P
Nephrol Dial Transplant; 2021 Dec; 37(1):100-107. PubMed ID: 33367877
[TBL] [Abstract][Full Text] [Related]
37. Copeptin is associated with mortality in elderly people.
Smaradottir MI; Andersen K; Gudnason V; Näsman P; Rydén L; Mellbin LG
Eur J Clin Invest; 2021 Jul; 51(7):e13516. PubMed ID: 33569762
[TBL] [Abstract][Full Text] [Related]
38. Effective prevention of cardiovascular disease and diabetes-related events with atorvastatin in Japanese elderly patients with type 2 diabetes mellitus: adjusting for treatment changes using a marginal structural proportional hazards model and a rank-preserving structural failure time model.
Shinozaki T; Matsuyama Y; Iimuro S; Umegaki H; Sakurai T; Araki A; Ohashi Y; Ito H;
Geriatr Gerontol Int; 2012 Apr; 12 Suppl 1():88-102. PubMed ID: 22435944
[TBL] [Abstract][Full Text] [Related]
39. Changes in Plasma Copeptin Levels during Hemodialysis: Are the Physiological Stimuli Active in Hemodialysis Patients?
Ettema EM; Kuipers J; Assa S; Bakker SJ; Groen H; Westerhuis R; Gaillard CA; Gansevoort RT; Franssen CF
PLoS One; 2015; 10(5):e0127116. PubMed ID: 25973954
[TBL] [Abstract][Full Text] [Related]
40. Complementary role of copeptin and high-sensitivity troponin in predicting outcome in patients with stable chronic heart failure.
Tentzeris I; Jarai R; Farhan S; Perkmann T; Schwarz MA; Jakl G; Wojta J; Huber K
Eur J Heart Fail; 2011 Jul; 13(7):726-33. PubMed ID: 21616953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
